Hepatitis B virus (HBV) infection remains a major public health problem despite the availability of an effective vaccine since 1982. HBV occurs worldwide and is associated with approximately 887 000 deaths each year, 1 mostly due to the chronic phase of infection.
and in some South American countries. 10 In central Africa, the seroprevalence of HBV has been estimated between 6% to 7%, 11 while the seroprevalence of HDV is 25% to 64% in HBsAg-positive populations in general and 37% to 77% in those also diagnosed with liver disease. 12 However, in this region of sub-Saharan Africa, survey data on local seroprevalence of HBV are incomplete in several countries and little is known about the origin, circulation, and genetic diversity of HDV in central Africa.
Hepatitis B virus has been classified into nine genotypes, designated A-I. Genotypes A-D, F, H, and I are classified further into at least 35 subgenotypes. 13 Some HBV genotypes are restricted to particular geographic regions while others are distributed globally. 14 In Africa, HBV genotypes A and E predominate. 15 HBV genotype E is particularly endemic in West Africa 16 and this appears to stretch into parts of central Africa as well. 17 HBV genotype A has also been reported from Africa. Subgenotype HBV/A1 has been found circulating widely in the continent while HBV/A3 has been reported mainly in West and central Africa. 18, 19 Hepatitis D virus is classified into eight major genotypes, named HDV-1 to HDV-8. 20 HDV genotypes and subgenotypes also have distinct geographic distributions. HDV-1 strains are the most prevalent worldwide, HDV-2 and -4 strains are restricted to Asia, HDV-3 appears to be restricted to the northern part of South America, and genotypes HDV-5 to HDV-8 are found only in Africa. 20 Few genotyping studies have been performed in central Africa, and often only in small populations. Genotype 1 was reported in Central African Republic 2 and in Democratic Republic of Congo, 21 while genotypes 1, 5, 6 and 7 were reported in Cameroon. 22 Previous sero-epidemiological studies conducted between 1988
and 2009 in Gabon showed a high prevalence of HBsAg (>8%) in various populations within the provinces of Haut-Ogooué, Ngounié, Woleu-Ntem and Ogooué-Ivindo and that about 60.0% of HBsAg positive individuals in Woleu-Ntem had antibodies to HDV. [23] [24] [25] [26] In these few, often restricted, study populations, circulation of HBV genotypes A3, A4, and E and HDV genotypes 1, 7, and 8 were reported. [24] [25] [26] [27] [28] Screening for HBV is carried out mainly in blood transfusion centres, after blood exposure accidents or in symptomatic patients (clinical jaundice) but broad therapeutic coverage does not extend to patients living in rural areas, despite a national policy of Universal Health Coverage and the existence of a social health insurance.
Furthermore, HBV vaccination has been implemented in infants in urban areas in Gabon since 2005, with an estimated immunization coverage between 71% to 82%, and to date, there is no HBV vaccination program in rural areas. 29, 30 As stated before, epidemiological and genetic patterns of HBV/HDV infection are extraordinarily heterogeneous.
Therefore, the limitation with these previous studies in central Africa is that this heterogeneity coincides with heterogeneities in demography, ecology, and viral exposure between small population subsets, which biases assessment of infection risk factors.
To deepen our knowledge on the distribution and the genetic diversity of these two viruses and identify robust risk factors, 
| Blood collection
Blood samples were collected, usually in local health care centres but also in the villages, as described elsewhere. 31 Plasma samples were stored at −80°C until use at the Centre International de Recherches
Médicales de Franceville (CIRMF), Gabon.
| Serological tests
Hepatitis B surface antigen was first assayed using the Monolisa™ HBsAg ULTRA kit (Bio-Rad, Marnes la Coquette, France), a fully multivalent assay showing high sensitivity in the detection of HBV mutants. Presence of HBeAg, a viral protein that circulates in infected blood when the virus is actively replicating, was determined in all HBsAg positive samples using the ETI-EBK PLUS kit (DiaSorin, Saluggia, Italy). All samples testing positive for HBsAg were then assessed for the presence of HDV using an HDV antibody kit (DIA.
PRO, Milan, Italy). All analyses were performed according to the manufacturers' instructions.
| RNA and DNA isolation
Viral DNA and RNA were extracted from 200 μL of plasma from all HBsAg positive samples using the QIAamp® MinElute® Virus Spin kit (Qiagen, Courtaboeuf, France) according to the manufacturer's instructions. Viral nucleic acids were then eluted in 50 μL of elution buffer and stored at −80°C.
| HBV and HDV genotyping
Hepatitis B virus genotypes were determined by phylogenetic analysis of a 377 bp fragment of the HBV S gene as described previously. 32 HDV genotypes were determined by phylogenetic analysis of the R0 region (400 bp) of the genome as described previously. 33 The ultra sensitive
RT-PCR amplification of this region covering the 19 specific amino acids of the large delta protein discriminates between all eight known HDV genotypes. 20 Raw HDV and HBV sequences were edited and manually corrected using Genious R7. Maximum-likelihood trees and genetic distances were calculated using MEGA7 software. 
| Ethnicity database
For this study, we relied on the "Atlas des Langues et peuples du
Gabon" to retrospectively assign ethnic groups to the database. 35 Ethnicities were recorded at the administrative level of 'department'
(within a 'province'), therefore, these data were not given for each individual but rather aggregated for analysis among provinces. There were 52 distinct ethnicities recognized.
| Statistical analysis
We tested for differences in HBV and HDV prevalence between administrative provinces in order to elucidate broad-scale geographic patterns using Chi-square tests. We then added de- Where differences between provinces were significant, we explored the hypothesis that these regions also differ in their ethnic composition. We first used multiple correspondence analysis (MCA)
to reduce the presence/absence data for each ethnic group down to a set of orthogonal continuous variables ('dimensions') that described the composition in each province (using function 'mca' in 
| RE SULTS

| HBV and HDV prevalence
The overall prevalence of HBsAg marker in the Gabonese rural population was 7.4% (303/4107). As shown in Figure 1 , prevalence did not differ significantly between the 9 provinces (6.1% to 8.8%, (Table 1) . However, apparent increased risk of infection among people with a secondary education, with a tattoo, or among the sexually-active supported by the crude odds ratios did not explain sufficient variance above gender and age in the multiple regression analysis. Of the 303 individuals with HBsAg, 15 were also positive for HBeAg (5.0%), but no significant differences between provinces (P = 0.11), gender (P = 0.79) or age class (P = 0.18) were noted (data not shown).
As shown in Figure 2 , 84 people were also positive for HDV antibody (anti-HDV) (27.7%) among the 303 HBsAg-positive individuals. Significant variability in plasma anti-HDV seroprevalence was observed among provinces (χ 2 = 82.12, df = 8, P < 0.0001; Figure 2 ). Particularly high seroprevalence for HDV was reported in three provinces in the northeast of Gabon: 66. TA B L E 1 ( Continued) Following multiple regression analyses, risk factors for exposure included age (higher seroprevalence in individuals under 60), prior hospitalization, having a tattoo, and having genital lesions, all of which had previously been identified in other populations. 43, 48, 49 But by far, the most important factor was geographic location. In the absence of comparable data on HDV circulation in the countries neighbouring Northern Gabon, it is difficult to explain these high rates in the Northeast of the country. Nevertheless, we found that differences in prevalence between the provinces correlated with ethnic composition, which may underlie genetic and cultural differences affecting vulnerability to infection. Such heterogeneity in infection risk among racial and ethnic groups has long been described for both HBV and HDV, but this is the first time it has been specifically considered in Central Africa. 50 20 This work represents the largest study of HBV and HDV seroprevalence in central Africa to date. The results confirmed that high exposure of the population of Gabon to HBV infection held F I G U R E 5 Phylogenetic tree of a 400 bp fragment of the HDV-R0 region using the neighbour-joining algorithm. For phylogenetic analysis, 42 HDV sequences from the Gabon (shown in red) were aligned with 82 available full-length genomic sequences using MEGA7 software. Numbers on the nodes of the tree give the bootstrap value of the node (500 replicates). The numbers (1 to 8) indicate the HDV genotype and letters, the subgenotypes. Maximum-likelihood tree and genetic distances were calculated with Hasegawa-Kishino-Yano (Gamma distributed with invariant) model true across the whole country, and showed that more than 25% of the HBsAg-positive population was infected by HDV. Although men could have higher susceptibility to HBV infection or chronicity, risk of HDV exposure was associated with prior hospitalizations, tattoos, and genital lesions; both viruses were more prevalent among younger age classes. Moreover, we reported a North-South split in the distribution of HDV seroprevalence, with the highest rates (>66.0%) correlating with the presence of specific ethnic groups in the northeastern provinces. Thus, when possible, we suggest that prevalence should be evaluated at the whole country level in order to highlight potential differences between regions and/or communities. 21, 51, 53, 54 This finding warrants further investigation to reveal whether specific genetic or cultural factors influence HDV transmission. Finally, HBV and HDV genotyping revealed a high genetic diversity of the strains circulating in Gabon, including many restricted to this region of the globe.
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